HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

Improvement of power lymphocytic leukemia (CLL) is related to extreme immune dysfunction. T-cell exhaustion, immune checkpoint upregulation, and enhance of regulatory T cells contribute to an immunosuppressive tumor microenvironment. Because of this, CLL sufferers are severely vulnerable to infectious problems … Read More